In 2015, Dai’s meta-analysis [51] including 11 studies showed that GP73 had a sensitivity of 0.77 and specificity of 0.91 in the diagnosis of HCC and a DOR of 12.49, which were better than AFP. This evidence concerns the gene GOLM1 and hepatocellular carcinoma.